Mouse models in tumor suppression

被引:62
作者
Ghebranious, N
Donehower, LA
机构
[1] Baylor Coll Med, Div Mol Virol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA
关键词
tumor suppressors; knockout mice; cancer models; inherited cancer syndromes;
D O I
10.1038/sj.onc.1202573
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic lesions found in tumors are often targeted to the negative growth regulatory tumor suppressor genes. Much of our understanding of tumor suppressor gene function is derived from experimental manipulations in cultured cells. Recently, however, the generation of mice with germ line tumor suppressor gene mutations through gene targeting in embryonic stem cells has provided another dimension by allowing experimental studies of tumor suppressor function in an organismal context. Novel insights into the role of tumor suppressors in development, differentiation, cell cycle control, and tumor suppression have been obtained from the studies on these 'knockout' mice, In addition, such mice may serve as disease models for humans with inherited cancer predisposition syndromes, Perhaps the greatest advantage of many of the mouse tumor suppressor models is that they facilitate study of the roles of tumor suppressor gene loss in tumor initiation and progression in vivo. Moreover, derivation of primary cells from tumor suppressor-deficient mice has provided an important resource for in vitro studies on the role of targeted genes in cell cycle regulation, DNA damage response, regulation of apoptotic pathways, and preservation of genomic stability. In this review, we discuss some of the mechanistic insights provided by tumor suppressor-deficient mice and their utility as models for human cancer syndromes.
引用
收藏
页码:3385 / 3400
页数:16
相关论文
共 243 条
[1]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[2]   ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J].
ASO, T ;
LANE, WS ;
CONAWAY, JW ;
CONAWAY, RC .
SCIENCE, 1995, 269 (5229) :1439-1443
[3]   NEUROFIBROMATOSIS AND CHILDHOOD LEUKEMIA [J].
BADER, JL ;
MILLER, RW .
JOURNAL OF PEDIATRICS, 1978, 92 (06) :925-929
[4]  
BAIRD PN, 1992, ONCOGENE, V7, P2141
[5]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[6]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[7]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[8]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[9]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[10]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125